Atlas Trials

Managed Access Programs for ABL001, Asciminib

Clinical trial NCT04360005 · AVAILABLE

Trial details

NCT number
NCT04360005
Sponsor
Novartis Pharmaceuticals
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Chronic Myeloid Leukemia in Chronic Phase

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.